Product
Recombinant Hepatitis B
Aliases
Recombinant Hepatitis B new Bulk vaccine
2 clinical trials
6 indications
Indication
Diphtheria Vaccine Adverse ReactionIndication
Tetanus vaccine adverse reactionIndication
Pertussis Vaccine Adverse ReactionIndication
Hepatitis B Vaccine Adverse ReactionIndication
ImmunogenicityClinical trial
Comparison of Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B at Birth Dose Using New Hepatitis B Bulk (Bio Farma), in Indonesian InfantsStatus: Not yet recruiting, Estimated PCD: 2025-04-01
Clinical trial
Protectivity and Safety Following Recombinant Hepatitis B Vaccine With Different Source of Hepatitis B Bulk Compared to Hepatitis B (Bio Farma) Vaccine in Indonesian PopulationStatus: Completed, Estimated PCD: 2020-01-30